Logo image of MYO

MYOMO INC (MYO) Stock Fundamental Analysis

USA - NYSEARCA:MYO - US62857J2015 - Common Stock

0.8225 USD
-0.06 (-6.46%)
Last: 9/16/2025, 8:04:00 PM
0.8199 USD
0 (-0.32%)
After Hours: 9/16/2025, 8:04:00 PM
Fundamental Rating

3

MYO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. MYO may be in some trouble as it scores bad on both profitability and health. MYO shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MYO had negative earnings in the past year.
In the past year MYO has reported a negative cash flow from operations.
MYO had negative earnings in each of the past 5 years.
In the past 5 years MYO always reported negative operating cash flow.
MYO Yearly Net Income VS EBIT VS OCF VS FCFMYO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of MYO (-24.11%) is comparable to the rest of the industry.
The Return On Equity of MYO (-52.93%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -24.11%
ROE -52.93%
ROIC N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
MYO Yearly ROA, ROE, ROICMYO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

The Gross Margin of MYO (69.24%) is better than 78.01% of its industry peers.
MYO's Gross Margin has improved in the last couple of years.
MYO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
MYO Yearly Profit, Operating, Gross MarginsMYO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

3

2. Health

2.1 Basic Checks

MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYO has more shares outstanding
MYO has more shares outstanding than it did 5 years ago.
MYO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MYO Yearly Shares OutstandingMYO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MYO Yearly Total Debt VS Total AssetsMYO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -2.31, we must say that MYO is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MYO (-2.31) is worse than 61.78% of its industry peers.
MYO has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.22, MYO is in line with its industry, outperforming 54.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z -2.31
ROIC/WACCN/A
WACC8.69%
MYO Yearly LT Debt VS Equity VS FCFMYO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 2.39 indicates that MYO has no problem at all paying its short term obligations.
With a Current ratio value of 2.39, MYO perfoms like the industry average, outperforming 47.64% of the companies in the same industry.
A Quick Ratio of 2.03 indicates that MYO has no problem at all paying its short term obligations.
With a Quick ratio value of 2.03, MYO perfoms like the industry average, outperforming 53.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 2.03
MYO Yearly Current Assets VS Current LiabilitesMYO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 11.54% over the past year.
The Revenue has grown by 93.07% in the past year. This is a very strong growth!
Measured over the past years, MYO shows a very strong growth in Revenue. The Revenue has been growing by 53.36% on average per year.
EPS 1Y (TTM)11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)93.07%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%28.34%

3.2 Future

The Earnings Per Share is expected to grow by 32.47% on average over the next years. This is a very strong growth
MYO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.80% yearly.
EPS Next Y-125.76%
EPS Next 2Y-24.88%
EPS Next 3Y14.34%
EPS Next 5Y32.47%
Revenue Next Year33.73%
Revenue Next 2Y28.52%
Revenue Next 3Y25.7%
Revenue Next 5Y23.8%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MYO Yearly Revenue VS EstimatesMYO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
MYO Yearly EPS VS EstimatesMYO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYO Price Earnings VS Forward Price EarningsMYO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYO Per share dataMYO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as MYO's earnings are expected to grow with 14.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.88%
EPS Next 3Y14.34%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYOMO INC

NYSEARCA:MYO (9/16/2025, 8:04:00 PM)

After market: 0.8199 0 (-0.32%)

0.8225

-0.06 (-6.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners55.66%
Inst Owner Change2.92%
Ins Owners5.48%
Ins Owner Change15.49%
Market Cap31.09M
Analysts80
Price Target5.41 (557.75%)
Short Float %4.49%
Short Ratio1.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.48%
Min EPS beat(2)-4.22%
Max EPS beat(2)-2.75%
EPS beat(4)2
Avg EPS beat(4)18.06%
Min EPS beat(4)-4.22%
Max EPS beat(4)50.5%
EPS beat(8)4
Avg EPS beat(8)17.38%
EPS beat(12)7
Avg EPS beat(12)14.73%
EPS beat(16)10
Avg EPS beat(16)13.79%
Revenue beat(2)2
Avg Revenue beat(2)5.03%
Min Revenue beat(2)4.48%
Max Revenue beat(2)5.57%
Revenue beat(4)4
Avg Revenue beat(4)10.8%
Min Revenue beat(4)4.48%
Max Revenue beat(4)20.73%
Revenue beat(8)6
Avg Revenue beat(8)6.89%
Revenue beat(12)8
Avg Revenue beat(12)5.03%
Revenue beat(16)12
Avg Revenue beat(16)10.75%
PT rev (1m)-39.08%
PT rev (3m)-41.44%
EPS NQ rev (1m)-37.82%
EPS NQ rev (3m)-1333.33%
EPS NY rev (1m)-227.59%
EPS NY rev (3m)-227.59%
Revenue NQ rev (1m)-12.14%
Revenue NQ rev (3m)-13.64%
Revenue NY rev (1m)-17.68%
Revenue NY rev (3m)-19.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 1.76
P/tB 1.76
EV/EBITDA N/A
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS1.08
BVpS0.47
TBVpS0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.11%
ROE -52.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69.24%
FCFM N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
F-Score3
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 212.49%
Cap/Sales 7.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 2.03
Altman-Z -2.31
F-Score3
WACC8.69%
ROIC/WACCN/A
Cap/Depr(3y)74.6%
Cap/Depr(5y)98.18%
Cap/Sales(3y)1.88%
Cap/Sales(5y)1.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next Y-125.76%
EPS Next 2Y-24.88%
EPS Next 3Y14.34%
EPS Next 5Y32.47%
Revenue 1Y (TTM)93.07%
Revenue growth 3Y32.93%
Revenue growth 5Y53.36%
Sales Q2Q%28.34%
Revenue Next Year33.73%
Revenue Next 2Y28.52%
Revenue Next 3Y25.7%
Revenue Next 5Y23.8%
EBIT growth 1Y1.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.3%
OCF growth 3YN/A
OCF growth 5YN/A